Description

1,28,68,000 equity shares of Ind-Swift Laboratories Ltd listed and permitted to trade on BSE effective October 7, 2025, issued at Rs. 121/- per share through preferential allotment pursuant to warrant conversion.

Summary

BSE has approved the listing of 1,28,68,000 equity shares of Ind-Swift Laboratories Ltd. (Scrip Code: 532305) with effect from Tuesday, October 7, 2025. These shares were issued at a premium of Rs. 111/- (face value Rs. 10/-) totaling Rs. 121/- per share to Promoters and Non-Promoters on a preferential basis pursuant to conversion of warrants. The shares rank pari-passu with existing equity shares.

Key Points

  • Total new shares listed: 1,28,68,000 equity shares of Rs. 10/- each
  • Issue price: Rs. 121/- per share (Rs. 10/- face value + Rs. 111/- premium)
  • Distribution numbers: 60618861 to 73486860
  • ISIN: INE915B01019
  • Shares issued through preferential allotment pursuant to warrant conversion
  • Multiple allotment dates: July 2, 2025 (65,82,876 shares), July 21, 2025 (51,85,124 shares), August 1, 2025 (11,00,000 shares)
  • Lock-in periods apply to all shares ranging from 2026 to 2027

Regulatory Changes

No regulatory changes introduced. This is a routine listing notification following preferential allotment procedures.

Compliance Requirements

  • Trading members must note the new securities are available for trading from October 7, 2025
  • Lock-in restrictions must be observed as per the specified schedule
  • Shares subject to lock-in cannot be transferred until respective lock-in expiry dates

Important Dates

  • October 6, 2025: Notice date
  • October 7, 2025: Trading commencement date for new securities
  • July 2, 2025: First allotment (65,82,876 shares)
  • July 21, 2025: Second allotment (51,85,124 shares)
  • August 1, 2025: Third allotment (11,00,000 shares)
  • April 10, 2026: Lock-in expiry for 99,67,000 shares (54,82,876 + 44,85,124)
  • April 10, 2027: Lock-in expiry for 29,00,000 shares (11,00,000 + 7,00,000 + 11,00,000)

Impact Assessment

Market Impact: Medium - The addition of 12.87 million shares represents significant equity dilution. The staggered allotment dates across July-August 2025 and lock-in periods extending to 2027 will limit immediate supply. The preferential allotment to both promoters and non-promoters at Rs. 121/- per share indicates confidence in the company’s valuation.

Operational Impact: Trading volumes may increase once shares become tradeable on October 7, 2025. However, with 100% of new shares under lock-in restrictions until 2026-2027, the immediate free float impact is minimal. Investors should monitor promoter holding changes and dilution effects on existing shareholders’ stake percentages.

Impact Justification

Significant equity dilution of 12.87 million shares through preferential allotment with lock-in periods, impacts existing shareholders and trading volumes